A Study of DS-7011a in Patients With Systemic Lupus Erythematosus

NCT05638802 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

26

Enrollment

INDUSTRY

Sponsor class

Conditions

Systemic Lupus Erythematosus

Interventions

DRUG: DS-7011a
DRUG: Placebo

Sponsor

Daiichi Sankyo